LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 44.21%156.9M | -27.29%150.5M | 44.39%29.6M | 4.44%515.6M | 1.07%179.3M | 44.68%108.8M | 13.11%207M | -64.72%20.5M | -10.51%493.7M | 5.66%177.4M |
Net income from continuing operations | 3.69%39.3M | 14.40%86.6M | -36.98%53M | -14.64%235M | -57.37%37.3M | -44.43%37.9M | 107.97%75.7M | 1.08%84.1M | -10.76%275.3M | -14.47%87.5M |
Operating gains losses | ---- | 87.50%-500K | 11.11%1M | -131.82%-2.8M | -350.00%-1.5M | 250.00%1.8M | -154.79%-4M | -57.14%900K | 728.57%8.8M | 127.27%600K |
Depreciation and amortization | 2.08%39.2M | 0.52%38.7M | 0.26%39.2M | -2.47%158M | 4.22%42M | -3.03%38.4M | -9.62%38.5M | -1.01%39.1M | 11.34%162M | -5.18%40.3M |
Deferred tax | 9.09%-3M | 34.88%-2.8M | -2.86%-3.6M | -1.30%-46.6M | -5.34%-35.5M | 17.50%-3.3M | -2.38%-4.3M | 14.63%-3.5M | 36.73%-46M | 41.90%-33.7M |
Other non cash items | -83.33%200K | -5,366.67%-15.8M | 0.00%3.1M | 200.00%11.9M | 108.57%7.3M | 134.29%1.2M | -96.74%300K | 114.69%3.1M | -144.57%-11.9M | 418.18%3.5M |
Change In working capital | 178.26%28.8M | -67.48%21.4M | 29.15%-93.8M | 93.33%-1.2M | 63.52%102.2M | 33.69%-36.8M | 16.87%65.8M | -62.85%-132.4M | -140.27%-18M | 10.04%62.5M |
-Change in receivables | 130.00%1.5M | -29.52%11.7M | 96.86%-1.1M | -2,660.00%-25.6M | 80.00%-2.2M | -233.33%-5M | 74.74%16.6M | -975.00%-35M | 113.33%1M | -22.22%-11M |
-Change in prepaid assets | 255.74%19M | 5,000.00%14.7M | -138.18%-6.3M | 75.35%-35M | 68.09%-39M | -195.31%-12.2M | 97.66%-300K | 183.33%16.5M | -593.06%-142M | -273.33%-122.2M |
-Change in payables and accrued expense | 142.35%8.3M | -110.10%-5M | 24.14%-86.4M | -51.71%59.4M | -26.72%143.4M | 70.66%-19.6M | -16.95%49.5M | -73.89%-113.9M | 425.64%123M | 4,263.83%195.7M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 44.21%156.9M | -27.29%150.5M | 44.39%29.6M | 4.44%515.6M | 1.07%179.3M | 44.68%108.8M | 13.11%207M | -64.72%20.5M | -10.51%493.7M | 5.66%177.4M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 277.51%323.6M | -2,247.73%-413.2M | -133.12%-35.9M | -221.98%-240.2M | 57.36%-24.9M | -456.75%-182.3M | -115.58%-17.6M | 91.46%-15.4M | 87.76%-74.6M | -46.00%-58.4M |
Capital expenditure reported | 39.13%-5.6M | 15.24%-8.9M | -30.86%-10.6M | -24.25%-37.4M | -2,020.00%-9.6M | -33.33%-9.2M | -2.94%-10.5M | 40.00%-8.1M | 9.06%-30.1M | 0.00%500K |
Net PPE purchase and sale | 36.84%-4.8M | -121.43%-9.3M | -180.00%-14M | 52.27%-32.6M | 47.33%-15.8M | 13.64%-7.6M | 74.55%-4.2M | 61.54%-5M | -44.09%-68.3M | -88.68%-30M |
Net intangibles purchase and sale | 93.88%-300K | -145.00%-4.9M | -390.48%-10.3M | 20.69%-9.2M | 94.87%-200K | -32.43%-4.9M | -25.00%-2M | 12.50%-2.1M | 39.27%-11.6M | 62.50%-3.9M |
Net business purchase and sale | ---- | ---- | ---- | -149.46%-161.4M | 97.70%-800K | ---- | ---- | ---- | 84.29%-64.7M | -145.07%-34.8M |
Net investment purchase and sale | --334.3M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 200.10%100.1M | --0 |
Net other investing changes | --0 | --0 | -400.00%-1M | --400K | --1.5M | --0 | ---900K | ---200K | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 277.51%323.6M | -2,247.73%-413.2M | -133.12%-35.9M | -221.98%-240.2M | 57.36%-24.9M | -456.75%-182.3M | -115.58%-17.6M | 91.46%-15.4M | 87.76%-74.6M | -46.00%-58.4M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -6,685.71%-47.5M | -713.21%-43.1M | 9.84%-5.5M | 97.21%-18.2M | 99.00%-6.1M | 97.78%-700K | 1.85%-5.3M | 1.61%-6.1M | -216.49%-652M | -12,583.33%-608.8M |
Net issuance payments of debt | ---9.5M | 0.00%-4.7M | 0.00%-4.8M | 24.74%-14.3M | 0.00%-4.8M | --0 | 0.00%-4.7M | 0.00%-4.8M | -118.76%-19M | 0.00%-4.8M |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Cash dividends paid | ---37.2M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | -14.29%-800K | -116.67%-1.3M | 46.15%-700K | 99.38%-3.9M | 99.78%-1.3M | 97.40%-700K | 14.29%-600K | 7.14%-1.3M | -5,175.00%-633M | ---604M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -6,685.71%-47.5M | -713.21%-43.1M | 9.84%-5.5M | 97.21%-18.2M | 99.00%-6.1M | 97.78%-700K | 1.85%-5.3M | 1.61%-6.1M | -216.49%-652M | -12,583.33%-608.8M |
Net cash flow | ||||||||||
Beginning cash position | -25.63%711.8M | 32.31%1.02B | 33.92%1.03B | -24.40%770.4M | -29.98%880.1M | -18.03%957.1M | -13.38%769M | -24.40%770.4M | 94.61%1.02B | 40.26%1.26B |
Current changes in cash | 683.56%433M | -266.11%-305.8M | -1,080.00%-11.8M | 210.43%257.2M | 130.28%148.3M | -178.35%-74.2M | -36.65%184.1M | 99.22%-1M | -146.39%-232.9M | -497.89%-489.8M |
Effect of exchange rate changes | 192.86%2.6M | -97.50%100K | -500.00%-2.4M | 126.11%4.1M | 3.13%3.3M | 47.17%-2.8M | 137.04%4M | 85.71%-400K | -137.88%-15.7M | 1,166.67%3.2M |
End cash Position | 30.37%1.15B | -25.63%711.8M | 32.31%1.02B | 33.92%1.03B | 33.92%1.03B | -29.98%880.1M | -18.03%957.1M | -13.38%769M | -24.40%770.4M | -24.40%770.4M |
Free cash flow | 67.85%146.2M | -33.05%127.4M | -200.00%-5.3M | 13.73%436.4M | 6.74%153.7M | 56.09%87.1M | 23.01%190.3M | -81.85%5.3M | -15.13%383.7M | 1.34%144M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |